CJC-1295 No DAC 5MG
CJC-1295 is a synthetic analog of the naturally occurring peptide GHRH (Growth Hormone-Releasing Hormone), commonly used in scientific research to stimulate pituitary growth hormone (GH) secretion. The “No DAC” formulation refers to the absence of des-acetamidated analogues, which can introduce variability in biological activity. This product is provided in a 5-mg vial, designed exclusively for experimental applications within a research setting.
Research Context
CJC-1295 has been investigated in academic and pharmaceutical research for its role in modulating growth hormone and insulin-like growth factor (IGF-1) signaling pathways. Its administration in animal models has been associated with increased growth, tissue repair, and metabolic effects. However, due to its potent biological activity, precise experimental protocols are essential to ensure reproducibility and safety in research settings.
Research Overview
CJC-1295 is typically administered as a subcutaneous injection in controlled research studies. Its efficacy has been explored in various physiological contexts, including aging, muscle atrophy, and regenerative medicine. Due to its high potency and potential for off-target effects, it is crucial that research protocols include appropriate monitoring, dosing adjustments, and ethical considerations for animal welfare.
Key Research Focus Areas
- Growth Hormone Stimulation: Investigation of GH release and subsequent IGF-1-dependent growth responses in experimental models.
- Metabolic Regulation: Examination of metabolic effects, including fat mass modulation and glucose metabolism in preclinical studies.
- Anti-Aging Mechanisms: Exploration of potential anti-aging properties through GH/IGF-1 signaling pathways in aged animal models.
- Muscle and Tissue Repair: Assessment of anabolic effects on muscle regeneration and tissue repair processes.
Safety and Compliance Considerations
This product is for research use only and should be handled with extreme caution. Research institutions must adhere to local regulations governing the storage, handling, and disposal of bioactive substances. Proper biosafety protocols, including containment measures and trained personnel, are mandatory to mitigate potential risks associated with CJC-1295 administration.
For research use only. Not for human or animal consumption.





Reviews
There are no reviews yet.